The tryptophan catabolite or kynurenine pathway in schizophrenia: meta-analysis reveals dissociations between central, serum, and plasma compartments
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The tryptophan catabolite or kynurenine pathway in schizophrenia: meta-analysis reveals dissociations between central, serum, and plasma compartments
Authors
Keywords
-
Journal
MOLECULAR PSYCHIATRY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-04-14
DOI
10.1038/s41380-022-01552-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inflammation and nitro-oxidative stress in current suicidal attempts and current suicidal ideation: a systematic review and meta-analysis
- (2022) Asara Vasupanrajit et al. MOLECULAR PSYCHIATRY
- Dysregulation of Kynurenine Pathway and Potential Dynamic Changes of Kynurenine in Schizophrenia: A Systematic Review and Meta-Analysis
- (2021) Bing Cao et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Inflammatory and Oxidative Pathways Are New Drug Targets in Multiple Episode Schizophrenia and Leaky Gut, Klebsiella pneumoniae, and C1q Immune Complexes Are Additional Drug Targets in First Episode Schizophrenia
- (2021) Michael Maes et al. MOLECULAR NEUROBIOLOGY
- Association of the kynurenine pathway metabolites with clinical, cognitive features and IL-1β levels in patients with schizophrenia spectrum disorder and their siblings
- (2021) Handan Noyan et al. SCHIZOPHRENIA RESEARCH
- Quinolinic acid is associated with cognitive deficits in schizophrenia but not major depressive disorder
- (2021) Flurin Cathomas et al. Scientific Reports
- The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
- (2021) Matthew J. Page et al. PLOS MEDICINE
- Effects of neuroactive metabolites of the tryptophan pathway on working memory and cortical thickness in schizophrenia
- (2021) Junchao Huang et al. Translational Psychiatry
- Associations Between the Kynurenine Pathway, Proinflammatory Cytokines, and Brain-Derived Neurotrophic Factor in Hospitalized Patients With Chronic Schizophrenia: A Preliminary Study
- (2021) Naomichi Okamoto et al. Frontiers in Psychiatry
- A Comparison of Serum and Plasma Blood Collection Tubes for the Integration of Epidemiological and Metabolomics Data
- (2021) Jennie Sotelo-Orozco et al. Frontiers in Molecular Biosciences
- Suicide attempts are associated with activated immune-inflammatory, nitro-oxidative, and neurotoxic pathways: A systematic review and meta-analysis
- (2021) Asara Vasupanrajit et al. JOURNAL OF AFFECTIVE DISORDERS
- Increased Levels of Plasma Tumor Necrosis Factor-α Mediate Schizophrenia Symptom Dimensions and Neurocognitive Impairments and Are Inversely Associated with Natural IgM Directed to Malondialdehyde and Paraoxonase 1 Activity
- (2020) Michael Maes et al. MOLECULAR NEUROBIOLOGY
- Immune and Neuroendocrine Trait and State Markers in Psychotic Illness: Decreased Kynurenines Marking Psychotic Exacerbations
- (2020) Livia De Picker et al. Frontiers in Immunology
- Preliminary comparative analysis of kynurenine pathway metabolites in chronic ketamine users, schizophrenic patients, and healthy controls
- (2020) Zhaohua Zhang et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Chronic fatigue and fibromyalgia symptoms are key components of deficit schizophrenia and are strongly associated with activated immune-inflammatory pathways
- (2020) Abbas F. Almulla et al. SCHIZOPHRENIA RESEARCH
- Blood-based kynurenine pathway alterations in schizophrenia spectrum disorders: A meta-analysis
- (2020) Manuel Morrens et al. SCHIZOPHRENIA RESEARCH
- The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studies
- (2020) Wolfgang Marx et al. MOLECULAR PSYCHIATRY
- Multivariate Analysis of Structural and Functional Neuroimaging Can Inform Psychiatric Differential Diagnosis
- (2020) Drozdstoy Stoyanov et al. Diagnostics
- Serum xanthurenic acid levels: Reduced in subjects at ultra high risk for psychosis
- (2019) Martina Curto et al. SCHIZOPHRENIA RESEARCH
- Metabolic dysfunctions in the kynurenine pathway, noradrenergic and purine metabolism in schizophrenia and bipolar disorders
- (2019) Nils Eiel Steen et al. PSYCHOLOGICAL MEDICINE
- Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia
- (2019) Jochen Kindler et al. MOLECULAR PSYCHIATRY
- The Role of Aberrations in the Immune-Inflammatory Response System (IRS) and the Compensatory Immune-Regulatory Reflex System (CIRS) in Different Phenotypes of Schizophrenia: the IRS-CIRS Theory of Schizophrenia
- (2019) Chutima Roomruangwong et al. MOLECULAR NEUROBIOLOGY
- Plasma xanthurenic acid in a context of insulin resistance and obesity in schizophrenia
- (2019) Gregory Oxenkrug et al. SCHIZOPHRENIA RESEARCH
- Peripheral immune aberrations in fibromyalgia: A systematic review, meta-analysis and meta-regression
- (2019) Laura Andrés-Rodríguez et al. BRAIN BEHAVIOR AND IMMUNITY
- Characterizing amino-acid biosignatures amongst individuals with schizophrenia: a case–control study
- (2018) Bing Cao et al. AMINO ACIDS
- Kynurenine is correlated with IL-1β in plasma of schizophrenia patients
- (2018) Helena P. G. Joaquim et al. JOURNAL OF NEURAL TRANSMISSION
- Influence of plasma cytokines on kynurenine and kynurenic acid in schizophrenia
- (2018) Joshua Chiappelli et al. NEUROPSYCHOPHARMACOLOGY
- Kynurenic Acid: The Janus-Faced Role of an Immunomodulatory Tryptophan Metabolite and Its Link to Pathological Conditions
- (2018) Elisa Wirthgen et al. Frontiers in Immunology
- Profiling of Amino Acids and Their Derivatives Biogenic Amines Before and After Antipsychotic Treatment in First-Episode Psychosis
- (2018) Liisa Leppik et al. Frontiers in Psychiatry
- Activation of the immune-inflammatory response system and the compensatory immune-regulatory system in antipsychotic naive first episode psychosis
- (2018) Mariane Nunes Noto et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Deficit, but Not Nondeficit, Schizophrenia Is Characterized by Mucosa-Associated Activation of the Tryptophan Catabolite (TRYCAT) Pathway with Highly Specific Increases in IgA Responses Directed to Picolinic, Xanthurenic, and Quinolinic Acid
- (2017) Buranee Kanchanatawan et al. MOLECULAR NEUROBIOLOGY
- Deficit Schizophrenia Is Characterized by Defects in IgM-Mediated Responses to Tryptophan Catabolites (TRYCATs): a Paradigm Shift Towards Defects in Natural Self-Regulatory Immune Responses Coupled with Mucosa-Derived TRYCAT Pathway Activation
- (2017) Buranee Kanchanatawan et al. MOLECULAR NEUROBIOLOGY
- Correlations of Kynurenic Acid, 3-Hydroxykynurenine, sIL-2R, IFN-α, and IL-4 with Clinical Symptoms During Acute Relapse of Schizophrenia
- (2017) Kinga Szymona et al. NEUROTOXICITY RESEARCH
- Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis
- (2017) Eric Plitman et al. SCHIZOPHRENIA BULLETIN
- Pilot study examining the relationship of childhood trauma, perceived stress, and medication use to serum kynurenic acid and kynurenine levels in schizophrenia
- (2017) Bridget J. Shovestul et al. SCHIZOPHRENIA RESEARCH
- Serum kynurenic acid is reduced in affective psychosis
- (2017) B E Wurfel et al. Translational Psychiatry
- Tryptophan Metabolism and White Matter Integrity in Schizophrenia
- (2016) Joshua Chiappelli et al. NEUROPSYCHOPHARMACOLOGY
- An enzyme in the kynurenine pathway that governs vulnerability to suicidal behavior by regulating excitotoxicity and neuroinflammation
- (2016) L Brundin et al. Translational Psychiatry
- Effect of various anticoagulants on the bioanalysis of drugs in rat blood: implication for pharmacokinetic studies of anticancer drugs
- (2016) Preeti Kulkarni et al. SpringerPlus
- Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia — significance for activation of the kynurenine pathway
- (2015) JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- Simultaneous determination of amino acids and neurotransmitters in plasma samples from schizophrenic patients by hydrophilic interaction liquid chromatography with tandem mass spectrometry
- (2015) Diego Soares Domingues et al. JOURNAL OF SEPARATION SCIENCE
- High predictive value of immune-inflammatory biomarkers for schizophrenia diagnosis and association with treatment resistance
- (2015) Cristiano Noto et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Xanthurenic Acid Activates mGlu2/3 Metabotropic Glutamate Receptors and is a Potential Trait Marker for Schizophrenia
- (2015) Francesco Fazio et al. Scientific Reports
- Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range
- (2015) Xiang Wan et al. BMC Medical Research Methodology
- Metabolomic profiling of schizophrenia patients at risk for metabolic syndrome
- (2014) R. Madelaine Paredes et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Putative Neuroprotective and Neurotoxic Kynurenine Pathway Metabolites Are Associated with Hippocampal and Amygdalar Volumes in Subjects with Major Depressive Disorder
- (2014) Jonathan Savitz et al. NEUROPSYCHOPHARMACOLOGY
- Kynurenines with Neuroactive and Redox Properties: Relevance to Aging and Brain Diseases
- (2014) Jazmin Reyes Ocampo et al. Oxidative Medicine and Cellular Longevity
- Quantitative Analyses of Schizophrenia-Associated Metabolites in Serum: Serum D-Lactate Levels Are Negatively Correlated with Gamma-Glutamylcysteine in Medicated Schizophrenia Patients
- (2014) Takeshi Fukushima et al. PLoS One
- Generation of superoxide anion radicals and platelet glutathione peroxidase activity in patients with schizophrenia
- (2014) Anna Dietrich-Muszalska et al. Neuropsychiatric Disease and Treatment
- A snapshot of plasma metabolites in first-episode schizophrenia: a capillary electrophoresis time-of-flight mass spectrometry study
- (2014) S Koike et al. Translational Psychiatry
- The KMO allele encoding Arg452 is associated with psychotic features in bipolar disorder type 1 and with increased CSF KYNA level and reduced KMO expression
- (2013) C Lavebratt et al. MOLECULAR PSYCHIATRY
- Kynurenines in the mammalian brain: when physiology meets pathology
- (2012) Robert Schwarcz et al. NATURE REVIEWS NEUROSCIENCE
- Schizophrenia: Linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment and neuroprogression
- (2012) George Anderson et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates—Nrf2 activators and GSK-3 inhibitors
- (2012) Michael Maes et al. INFLAMMOPHARMACOLOGY
- The Tryptophan Metabolite 3-Hydroxyanthranilic Acid Plays Anti-Inflammatory and Neuroprotective Roles During Inflammation
- (2011) Daniela Krause et al. AMERICAN JOURNAL OF PATHOLOGY
- Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naïve and medication-free schizophrenic patients
- (2011) A.M. Myint et al. BRAIN BEHAVIOR AND IMMUNITY
- 3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-naive patients with schizophrenia
- (2011) Ruth Condray et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Kynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controls
- (2011) Maria Holtze JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- Interaction and transport of kynurenic acid via human organic anion transporters hOAT1 and hOAT3
- (2011) Yuichi Uwai et al. PHARMACOLOGICAL RESEARCH
- The new ‘5-HT’ hypothesis of depression: Cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression
- (2010) M. Maes et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Decreased plasma tryptophan and tryptophan/large neutral amino acid ratio in patients with neuroleptic-resistant schizophrenia: Relationship to plasma cortisol concentration
- (2010) Myung Lee et al. PSYCHIATRY RESEARCH
- Impaired Kynurenine Pathway Metabolism in The Prefrontal Cortex of Individuals With Schizophrenia
- (2010) K. V. Sathyasaikumar et al. SCHIZOPHRENIA BULLETIN
- Increased Levels of Kynurenine and Kynurenic Acid in the CSF of Patients With Schizophrenia
- (2010) K. R. Linderholm et al. SCHIZOPHRENIA BULLETIN
- Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia
- (2009) J K Yao et al. MOLECULAR PSYCHIATRY
- Cytokine Changes and Tryptophan Metabolites in Medication-Naïve and Medication-Free Schizophrenic Patients
- (2009) Yong-Ku Kim et al. NEUROPSYCHOBIOLOGY
- Kynurenine pathway in psychosis: evidence of increased tryptophan degradation
- (2008) S Barry et al. JOURNAL OF PSYCHOPHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now